41.70
0.00
(0.00%)
At close: January 16 at 3:19:35 PM GMT+3
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,134,773.90
1,176,763.62
1,122,397.03
951,887.50
764,055.60
Cost of Revenue
755,479.17
743,619.19
702,725.85
587,840.13
511,226.06
Gross Profit
379,294.74
433,144.42
419,671.17
364,047.37
252,829.54
Operating Expense
95,250.94
107,813.03
139,449.45
226,362.32
141,308.30
Operating Income
284,043.80
325,331.39
280,221.73
137,685.05
111,521.23
Net Non Operating Interest Income Expense
-19,986.73
-25,804.31
-21,709.42
-15,717.12
-25,051.81
Pretax Income
344,851.46
320,955.29
274,150.97
117,560.46
84,206.20
Tax Provision
18,624.41
17,624.41
16,814.80
18,692.34
19,883.95
Net Income Common Stockholders
326,227.05
303,330.87
257,336.17
90,087.84
130,826.96
Diluted NI Available to Com Stockholders
326,227.05
303,330.87
257,336.17
90,087.84
130,826.96
Basic EPS
2.04
1.90
1.61
0.56
0.82
Diluted EPS
2.04
1.90
1.61
0.56
0.82
Basic Average Shares
160,000.00
160,000.00
160,000.00
160,000.00
160,000.00
Diluted Average Shares
160,000.00
160,000.00
160,000.00
160,000.00
160,000.00
Total Operating Income as Reported
358,034.71
342,574.86
291,784.96
131,229.21
109,258.01
Rent Expense Supplemental
--
452.28
2,934.93
74.50
2,485.40
Total Expenses
850,730.11
851,432.23
842,175.30
814,202.44
652,534.36
Net Income from Continuing & Discontinued Operation
326,227.05
303,330.87
257,336.17
90,087.84
130,826.96
Normalized Income
276,847.49
307,629.87
257,336.17
116,680.31
68,137.14
Interest Expense
23,911.76
25,804.31
21,709.42
15,717.12
25,051.81
Net Interest Income
-19,986.73
-25,804.31
-21,709.42
-15,717.12
-25,051.81
EBIT
368,763.22
346,759.60
295,860.38
133,277.58
109,258.01
EBITDA
466,478.87
446,860.07
396,273.89
242,707.80
213,139.53
Reconciled Cost of Revenue
755,479.17
743,619.19
702,725.85
587,840.13
511,226.06
Reconciled Depreciation
97,715.65
100,100.47
100,413.51
109,430.22
103,881.53
Net Income from Continuing Operation Net Minority Interest
326,227.05
303,330.87
257,336.17
98,868.13
64,322.25
Total Unusual Items Excluding Goodwill
52,198.66
-4,548.79
--
-9,658.99
-4,994.19
Total Unusual Items
52,198.66
-4,548.79
--
30.00
-4,994.19
Normalized EBITDA
414,280.21
451,408.85
396,273.89
242,677.81
218,133.72
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
2,819.10
-249.78
--
-1,535.80
-1,179.30
12/31/2020 - 7/15/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4002.SR Mouwasat Medical Services Company
91.80
+0.88%
4009.SR Middle East Healthcare Company
74.90
+0.54%
4004.SR Dallah Healthcare Company
155.60
-0.13%
9594.SR Al-Modawat Specialized Medical
16.50
-0.12%
2140.SR Ayyan Investment Company
16.16
+0.50%
4005.SR National Medical Care Company
158.00
-1.13%
4013.SR Dr. Sulaiman Al Habib Medical Services Group Company
291.20
-2.54%
4017.SR Dr. Soliman Abdel Kader Fakeeh
68.90
+0.15%
4018.SR Almoosa Health Company
140.80
-0.71%
HWAIF Healwell AI Inc.
1.2430
+0.24%